Cybin (NYSE American: CYBN | NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary...
The article Top 5 Psychedelic Milestones of 2022 was originally published on Microdose. As we turn the final pages of 2022, it’s important to take a...
It is currently as good a time as ever for long-term investors to buy stocks. With that in mind, I decided to look for seven cheap...
It has been quite a year for the psychedelics industry. We’ve experienced our fair share of ups and downs, opportunities and uncertainties, and a great...
The article Breaking News: Quebec First Province to Cover Costs of Psilocybin Therapy was originally published on Microdose. Quebec doctors have successfully...
Company also closed a C$3 million capital raise. The post Psyence Gets Rights For Psilocybin Drug For Palliative Care appeared first on Green Market R...
The article PharmaTher Receives FDA Orphan Drug Designation for Ketamine was originally published on Microdose. For more on Pharmather, check out PharmaTher...
Company also closed a C$3 million capital raise. The post Psyence Gets Approval For Psilocybin Drug For Palliative Care appeared first on Green Market...
The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost The post Awakn set to research...
Field Trip Health & Wellness Ltd. (TSXV: FTHW), a global leader in the delivery of psychedelic therapies, today announced that Ronan Levy, Chairman...